ChemoCentryx Inc CCXI Financial and Strategic SWOT Analysis Review Report...
SummaryChemoCentryx Inc ChemoCentryx is a biopharmaceutical company that discovers develops and commercializes orallyadministered therapeutics for the treatment of cancer autoimmune diseases and...
View ArticleJPMorgan Chase & Co notifies 3.12 shareholding in TiGenix
Leuven Belgium November 24 2017 2200h CEST TiGenix NV Euronext Brussels and Nasdaq TIG; "TiGenix" publishes today a transparency notification pursuant to Article 14 of the Belgian Law...
View ArticleMycenax Biotech Inc 4726 Financial and Strategic SWOT Analysis Review Report...
SummaryMycenax Biotech Inc Mycenax is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company's pipeline portfolio encompasses investigational candidates...
View ArticleNeovacs SA ALNEV Financial and Strategic SWOT Analysis Review Report Updated...
SummaryNeovacs SA Neovacs is a biotechnology company which develops various therapeutic vaccines for autoimmune disorders inflammatory diseases and cancers. The company offers TNF kinoid and IFNa...
View ArticlePublic offering nets $56.6mm for Assembly Biosciences
Assembly Biosciences Inc. netted $56.6mm through the public sale of 2.2mm common shares at $27.25. The company is developing treatments for hepatitis B and also for diseases associated with the...
View ArticleGalapagos NV GLPG Financial and Strategic SWOT Analysis Review Report Updated...
SummaryGalapagos NV Galapagos is a biotechnology company that discovers and develops pharmaceutical products. The company's product pipeline encompasses investigational candidates targeted at the...
View ArticleFred Hutchinson Cancer Research Center Pharmaceuticals Healthcare Deals and...
SummaryFred Hutchinson Cancer Research Center Fred Hutchinson a subsidiary of National Comprehensive Cancer Network is a nonprofit organization which conducts research on the prevention diagnose and...
View ArticleQu Biologics Inc Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryQu Biologics Inc Qu Biologics is a developer of site specific immunotherapy. The company develops a proprietary technology platform that is designed to treat immunerelated diseases and cancer....
View ArticleTransparency Information
PRESS RELEASEREGULATED INFORMATION Transparency Information Leuven BELGIUM November 30 2017 2200h CET TiGenix NV Euronext Brussels and Nasdaq TIG publishes information in accordance with articles 15...
View ArticleInDex Pharmaceuticals Holding AB INDEX Financial and Strategic SWOT Analysis...
SummaryInDex Pharmaceuticals Holding AB InDex Pharmaceuticals is a pharmaceutical development company that offers treatments for immunological diseases. The company provides lead compound kappaproct...
View ArticleTiGenix NV TIG Financial and Strategic SWOT Analysis Review Report Updated...
SummaryTiGenix NV TiGenix is a biopharmaceutical company that develops and commercializes novel therapeutics. Its product portfolio includes AlloCSC01 AlloCSC02 Cx611 and Cx601. The company develops...
View ArticleTxCell SA TXCL Financial and Strategic SWOT Analysis Review Report Updated...
SummaryTxcell SA Txcell is a biotechnology company that develops and innovates cellbased immunotherapy utilizing antigen specific regulatory Tcells. The company's pipeline products include cartreg...
View ArticleChanging gut bacteria in Crohns disease
A single enzyme altered the mix of bacteria in the guts of mice and led to inflammatory bowel disease. The study suggests a potential treatment target for diseases such as Crohns disease and ulcerative...
View ArticleCalciMedica Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report...
SummaryCalciMedica Inc CalciMedica is a pharmaceutical company that develops small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The...
View ArticleViaDerma Inc. Looks to have Sales Representatives Selling its FDA Registered...
LOS ANGELES CAMarketwired December 07 2017 ViaDerma Inc. OTC PINK VDRM a specialty pharmaceutical company devoted to bringing new products to market recently announced today that the Company has begun...
View ArticleMedical News Today Colitis and Crohn's Is 21st century living to blame
It is not clear why some people develop inflammatory bowel disorders and some don't. Research now shows that our lifestyle plays a significant part.
View ArticleSigmoid Pharma Ltd Pharmaceuticals Healthcare Deals and Alliances Profile...
SummarySigmoid Pharma Ltd Sigmoid formerly known as Sigmoid Biotechnologies Ltd is a specialty pharmaceutical company which develops new therapies for unmet clinical needs in gastrointestinal and...
View ArticleCoherus BioSciences Inc CHRS Financial and Strategic SWOT Analysis Review...
SummaryCoherus BioSciences Inc Coherus BioSciences formerly known as BioGenerics Inc is a biosimilar platform company that develops and commercializes biosimilar drugs. The company's pipeline product...
View ArticleProtein Phosphatase 2A PP2A or EC 3.1.3.16 Pipeline Review H2 2017 Report...
Protein Phosphatase 2A PP2A or EC 3.1.3.16 Pipeline Review H2 2017SummaryAccording to the recently published report 'Protein Phosphatase 2A Pipeline Review H2 2017'; Protein Phosphatase 2A PP2A or EC...
View Article